Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
doi 10.1530/ey.16.14.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Analysis of Overall Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Vaccine, Nilutamide, and Combination Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

A Dynamic Approach for Budget Impact Analysis (BIA) in Oncology: Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) as an Illustrative Example

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Effect of Dutasteride on Castration‑resistant Prostate Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression

Future Oncology
MedicineCancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy